Having fully stocked cart to treat malignant hyperthermia during labor not cost-beneficial

April 18, 2018, American Society of Anesthesiologists

Maintaining a stocked cart, with a full supply of the life-saving drug dantrolene, to treat malignant hyperthermia, a rare but potentially fatal adverse reaction to general anesthesia, may not be cost-beneficial in hospital maternity units where the incidence of the reaction is low, according to a new paper published in the Online First edition of Anesthesiology, the peer-reviewed medical journal of the American Society of Anesthesiologists (ASA).

Instead, researchers recommend hospitals keep a small dose of dantrolene in units for initial treatment, and a more centrally located stocked cart, often found in operating rooms, containing a full supply of dantrolene, other drugs and supplies be available for patients within 30 minutes of the decision to treat the reaction.

The effects of malignant are sudden and characterized by rapid heart rate, a dramatic spike in temperature, and muscle rigidity. A patient's susceptibility for developing the condition is inherited. Prompt availability of dantrolene is important for treating malignant hyperthermia and has resulted in lowered mortality rates. The Malignant Hyperthermia Association of the United States (MHAUS) recommends that dantrolene be available for administration within 10 minutes to combat the effects of malignant hyperthermia.

"We've moved to the point where almost all cesarean sections are done under regional anesthesia. Today it is rare for maternity units to use general anesthetics that might trigger malignant hyperthermia," said Edward Riley, M.D., senior author and professor of anesthesiology, perioperative and pain medicine at Stanford University in California.

He noted that an institution, which delivers 6,000 babies a year and has a 30 percent cesarean delivery rate and a 5 percent rate, will use general anesthesia less than 100 times a year. With the expected malignant hyperthermia incidence of one case per 170,698 anesthetics, the maternity unit in that institution would expect to have one malignant hyperthermia case every 1,700 years.

"At Stanford, if a complicated delivery is done under general anesthesia, the procedure is often performed in an operating room instead of the maternity unit in order to have access to a higher level of care, which includes access to a fully stocked cart to treat potential malignant hyperthermia," Dr. Riley said.

The researchers calculated the total annual cost of placing a fully stocked malignant hyperthermia cart in a maternity unit to be $2,016. They performed a cost-benefit analysis of maintaining a cart in or near maternity units, versus having a dantrolene treatment dose of 250 mg available, in every maternity unit in the United States.

The cost-benefit analysis showed the costs associated with maintaining the cart with a full supply of dantrolene, within 10 minutes of a maternity unit, exceeded the potential benefits. Additionally, the more cost-beneficial approach would be to keep a 250 mg dose of dantrolene on the unit for starting therapy.

"Because of the low incidence of malignant hyperthermia during labor and delivery, the costs associated with maintaining a fully stocked cart in hospital maternity units could ultimately be diverted to resources for other initiatives that may have a larger impact on patient safety and reducing maternal morbidity or mortality, for example, the provision of equipment to treat difficult airways," said Dr. Riley.

Explore further: Preparing for anesthesia: Five tips you should know

Related Stories

Preparing for anesthesia: Five tips you should know

April 7, 2017
(HealthDay)—If you have surgery on your calendar, don't wait until the last minute to start preparing, especially if you're going to need anesthesia.

Chemo plus hyperthermia active in advanced pancreatic cancer

July 31, 2017
(HealthDay)—For patients with locally advanced or metastatic pancreatic carcinoma with malignant ascites, a combined systemic and intraperitoneal chemotherapy approach plus hyperthermia is well tolerated and active, according ...

Misoprostol should be considered in postpartum hyperthermia

May 11, 2016
(HealthDay)—The synthetic prostaglandin E1 analogue misoprostol has known severe side effects and should be considered in cases of postpartum hyperthermia, rigors, and tachycardia, according to a case report published in ...

Whole-body heat stress lowers exercise capacity, blood flow in men

February 2, 2017
Researchers have found that prolonged exposure to high temperatures can raise both the skin and core temperature, reducing blood flow to the brain and limbs during exercise and limiting the ability to exercise for long periods. ...

Males with BRCA mutations have increased risk of certain cancers

April 17, 2018
(HealthDay)—Males with BRCA mutations have increased incidence of malignant disease, specifically prostate, melanoma, pancreas, and breast cancers, according to a research letter published online April 12 in JAMA Oncology.

Scientists confirm correlation between malignant hyperthermia and exertional heat stroke

May 11, 2017
New research published online in The FASEB Journal may ultimately help athletes and trainers better understand who may be more at risk for heat stroke. In the report, scientists use animals to show that there is a link between ...

Recommended for you

Surgeons have substantial impact on genetic testing in breast cancer patients who need it

July 3, 2018
For many women diagnosed with breast cancer, genetic testing can offer important information that might guide treatment choices. But studies have shown that only about half of women who could benefit receive genetic testing.

First major study comparing robotic to open surgery published in The Lancet

June 21, 2018
The first comprehensive study comparing the outcomes of robotic surgery to those of traditional open surgery in any organ has found that the surgeries are equally effective in treating bladder cancer. The seven-year study, ...

Antibodies may predict transplant rejection risk

June 19, 2018
The presence of certain antibodies in patients may suggest a higher risk of transplant rejection across multiple organ types, including the kidney, liver, heart and lungs, according to a new study published in PLOS Medicine.

First human test of robotic eye surgery a success

June 18, 2018
Researchers from the University of Oxford have completed the first successful trial of robot-assisted retinal surgery.

Surgical blood transfusions tied to clot risk

June 13, 2018
(HealthDay)—Blood transfusions around the time of surgery may raise your risk for dangerous blood clots, researchers say.

Tonsil and adenoid removal associated with respiratory, allergic and infectious disease

June 7, 2018
Tonsil and adenoid removal associated with long-term risks of respiratory, allergic and infectious diseases Removing tonsils and adenoids in childhood increases the long-term risk of respiratory, allergic and infectious diseases, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.